Kestra Medical insider plans sale of 6,275 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. insider Alfred J. Ford filed notice of a planned sale of 6,275 shares of common stock through Merrill Lynch on NASDAQ on 08/04/2026, with an indicated value of $151,140.78. These shares relate to restricted stock units that vest on 07/17/2026 under the issuer’s equity compensation plan.
Over the prior three months, Alfred J. Ford reported sales of 5,936 shares for $135,120.73 on 07/30/2026, 8,681 shares for $196,284.58 on 07/31/2026, and 13,015 shares for $311,118.83 on 08/03/2026.
Key Figures
Key Terms
Form 144 regulatory
restricted stock unit awards financial
equity compensation plan financial
common stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Kestra Medical Technologies (KMTS) report in this Form 144?
What KMTS insider sales were made in the past three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.